Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company’s neutrolin is a catheter lock solution for the prevention of catheter related bloodstream infections. Its neutrolin is a novel formulation of taurolidine, citrate and heparin that provides preventative solution by decreasing the triple threat of infection. CorMedix is also develop...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.